ARCHIMED-backed BOMI Group Completes Six Add-on Acquisitions

UPS Acquires Bomi Group from ARCHIMED

December 16, 2021

Logistics & Distribution

UPS has agreed to acquire Italy-headquartered healthcare logistics provider Bomi Group from ARCHIMED's MED Platform I. ARCHIMED, which took Bomi private in 2019, will exit after helping internationalize and grow the business; Bomi's management and founding family will remain in place following the transaction.

Bomi Group Acquires Integrated Logistics Services (ILS) in Ecuador and Peru

August 14, 2019

Logistics & Distribution

Bomi Group has acquired 100% of the share capital of a group of five companies operating as Integrated Logistics Services (ILS) across Ecuador and Peru. The deal expands Bomi's presence in Latin America and strengthens its pharma and animal-health cold-chain, warehousing and distribution capabilities (ILS operates in Quito, Guayaquil, Cuenca and Lima and provides 45,000 sqm of warehousing, 1,500 m³ of cold rooms and a 120-truck fleet).

ARCHIMED Acquires BioVendor Group

March 11, 2025

Medical Devices

ARCHIMED, a Europe-focused private equity firm specializing in healthcare, has acquired BioVendor Group, a Brno-headquartered developer and manufacturer of in‑vitro diagnostics and immunoassays. ARCHIMED will partner with existing management to accelerate internationalization, product innovation and commercial expansion as part of its MED III fund's diagnostics investment strategy.

ARCHIMED Acquires and Merges Symbio and Proinnovera to Form Symbio Proinnovera

November 17, 2023

Healthcare Services

ARCHIMED has acquired US-based Symbio and Germany-based Proinnovera in an all-equity deal and merged them to create Symbio Proinnovera, a specialized dermatology-focused CRO. The combined group will offer end-to-end dermatology consulting, formulation, testing and clinical research across North America and Europe, with founders rolling equity into the new platform and ARCHIMED-appointed operating partners joining the board to drive growth and further acquisitions.

ARCHIMED Acquires Majority Stake in Cube (Cube Biotech)

November 3, 2021

Biotechnology

Transatlantic healthcare private equity firm ARCHIMED has purchased a majority stake in Monheim, Germany-based Cube (Cube Biotech), a specialist provider of high-purity, stable membrane proteins for drug discovery. ARCHIMED will support Cube's US market expansion and broaden its product and service offering organically and via acquisitions while Cube's founding management remain significant shareholders and continue to lead the business.

ARCHIMED (via MED Platform I) Acquires Majority Stake in SUANFARMA

November 18, 2021

Pharmaceuticals

Transatlantic healthcare-focused private equity firm ARCHIMED, through its MED Platform I (MPI) fund, has acquired a majority stake in Madrid-based SUANFARMA, a manufacturer and distributor of active pharmaceutical ingredients (APIs) and nutraceutical ingredients. Ares Management provided debt financing for the transaction; SUANFARMA founder Héctor Ara and members of management rolled a material minority stake into the business and remain significant shareholders.